Implementation of Online Advance Care Planning Tool for (Hemato-)Oncological Patients Within the Cancer Network Concord
INDEED
2 other identifiers
observational
30
1 country
1
Brief Summary
The aim of this mixed-methods study is to describe both the implementation process and outcomes of the online module Advance Care Plan for (hemato-)oncology patients within the oncology-network CONCORD. The main question is: How is implementation and assurance of the advance care plan in daily care for (hemato-)oncological patients within CONCORD achieved, so that early integration of advance care planning in oncological care takes place and patient preferences are discussed? Healthcare providers and patients are asked to use the module and share their experiences with it.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Oct 2023
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2023
CompletedFirst Submitted
Initial submission to the registry
December 6, 2023
CompletedFirst Posted
Study publicly available on registry
April 8, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
April 8, 2024
April 1, 2024
2.7 years
December 6, 2023
April 3, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Implementation outcome
Fidelity to the tailored implementation of the ACP-tool
3 years
Secondary Outcomes (2)
Intervention outcome
3 years
Implementation outcome
3 years
Eligibility Criteria
Patients diagnosed with all types of (advanced)cancer.
You may qualify if:
- Cancer
- Treated by hospital from the CONCORD-network
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Erasmus Medical Centerlead
- Maasstad Hospitalcollaborator
- Spijkenisse Medical Centercollaborator
- Franciscus &Vlietlandcollaborator
- IJssellandcollaborator
- Ikazia Hospital, Rotterdamcollaborator
- Van Weel-Bethesda hospitalcollaborator
- Albert Schweitzer Hospitalcollaborator
- Beatrix hospitalcollaborator
Study Sites (1)
Joica Benschop
Rotterdam, 3023TB, Netherlands
MeSH Terms
Conditions
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 3 Years
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
December 6, 2023
First Posted
April 8, 2024
Study Start
October 1, 2023
Primary Completion (Estimated)
June 30, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
April 8, 2024
Record last verified: 2024-04